SCHEMBL3695591

SCHEMBL3695591

CC(N)=NC1=Nc2cc(OC(F)(F)F)ccc2CS1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.35
NOS3 P29474 2/20 0.34
NOS1 P29475 2/20 0.34
NOS2 P35228 2/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
GMNN O75496 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33
ALOX15 P16050 1/20 0.33
NFKB1 P19838 1/20 0.33
SLC6A2 P23975 1/20 0.33
SCN4A P35499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3696890 0.90 CTSL (0.35) CTSLNOS3NOS1NOS2NPC1
SCHEMBL3025619 0.85 HCRTR2 (0.32) NOS3NOS1NOS2DYRK1ABACE1
SCHEMBL3025621 0.82 PRMT6 (0.30) NOS3NOS1NOS2PRMT6
SCHEMBL3021993 0.78 HCRTR2 (0.33) NOS3NOS1NOS2DYRK1AGRIN2B
SCHEMBL3022781 0.78 HCRTR2 (0.33) NOS3NOS1NOS2DYRK1AGRIN2B
SCHEMBL3021991 0.74 GRIN2B (0.31) NOS3NOS1NOS2GRIN2BPRMT6
SCHEMBL3029229 0.74 GRIN2B (0.31) NOS3NOS1NOS2GRIN2BPRMT6
SCHEMBL3028857 0.67 SCN9A (0.41) CTSLNPC1RAB9AGMNNUSP2
SCHEMBL3025257 0.66 CTSL (0.32) CTSLNOS3NOS1NOS2DYRK1A
SCHEMBL3025253 0.66 CTSL (0.32) CTSLNOS3NOS1NOS2DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2190829-A2 AMIDINE, THIOUREA AND GUANIDINE DERIVATIVES OF 2-AMINOBENZOTHIAZOLES AND AMINOBENZOTHIAZINES FOR THEIR USE AS PHARMACOLOGICAL AGENTS FOR THE TREATMENT OF NEURODEGENERATIVE PATHOLOGIES Rottapharm S.p.A. (IT) 2010-06-02 EP disclosed
WO-2009040331-A2 AMIDINE, THIOUREA AND GUANIDINE DERIVATIVES OF 2-AMINOBENZOTHIAZOLES AND AMINOBENZOTHIAZINES FOR THEIR USE AS PHARMACOLOGICAL AGENTS FOR THE TREATMENT OF NEURODEGENERATIVE PATHOLOGIES ROTTAPHARM S.P.A. (IT) 2009-04-02 WO disclosed